STERIS plc (STE) is a publicly traded Healthcare sector company. As of May 20, 2026, STE trades at $216.65 with a market cap of $20.88B and a P/E ratio of 29.98. STE moved +0.49% today. Year to date, STE is -15.88%; over the trailing twelve months it is -13.77%. Its 52-week range spans $195.14 to $269.44. Analyst consensus is buy with an average price target of $284.50. Rallies surfaces STE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded STE stock?
Recent politician trading activity in STE includes disclosures from Gilbert Cisneros, April Delaney, April Delaney, April Delaney, and Rob Bresnahan. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
STE Key Metrics
Key financial metrics for STE
Metric
Value
Price
$216.65
Market Cap
$20.88B
P/E Ratio
29.98
EPS
$7.20
Dividend Yield
0.63%
52-Week High
$269.44
52-Week Low
$195.14
Volume
682.73K
Avg Volume
0
Revenue (TTM)
$5.83B
Net Income
$710.77M
Gross Margin
44.11%
Congressional Trades in STE
Gilbert Cisneros purchase STE on Feb 10, 2026 (amount: $15.00K).
April Delaney purchase STE on Feb 6, 2026 (amount: $15.00K).
April Delaney purchase STE on Sep 18, 2025 (amount: $15.00K).
April Delaney purchase STE on Sep 11, 2025 (amount: $15.00K).
Rob Bresnahan purchase STE on Feb 25, 2025 (amount: $15.00K).
Recent politician trading activity in STE includes disclosures from Gilbert Cisneros, April Delaney, April Delaney, April Delaney, and Rob Bresnahan. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in STE?
Yes. Rallies tracks politician and congressional stock disclosures for STE, including reported purchases, sales, dates, owners, and trade amounts when available.
Is STE research on Rallies investment advice?
No. Rallies provides research, data, and educational context for STE. It does not provide personalized investment advice.